Portal Login:
  • Clients
  • Providers
  • Skip to primary navigation
  • Skip to content
  • Skip to primary sidebar
  • Skip to footer
    Portal Login:
  • Clients
  • Providers
  • About MCN
  • Careers
  • MCNTalk
  • Contact Us

MCN | Medical Consultants Network

The Power of a Second Look

  • Services
    • Independent Medical Examinations
    • Medical Peer Reviews
    • Bill Review Services
    • Utilization Reviews
  • Expertise
    • Short and Long-Term Disability
    • Workers’ Compensation
    • Auto/PIP/Casualty/Liability
    • Independent Review Organization Services
  • For Clients
  • For Providers
  • Your Exam
    • About Your Exam
    • About Your External Review
    • Contact & Scheduling
  • Schedule Now
  • About MCN
  • MCNTalk
  • Careers
  • Contact Us

MCNTalk
News, Insights & Opinions

Home / MCNTalk / Narcotic Subsys Draws Attention

May 15, 2014

Narcotic Subsys Draws Attention

Last week we blogged about controversy over Zohydro, an opioid approved last fall by the FDA. Another narcotic, Subsys, is generating attention, as is maker Insys Therapeutics. Subsys, a form of fentanyl which is sprayed under the tongue, is a narcotic used when painkillers such as morphine aren’t effective. Subsys was approved by the FDA in 2012 to treat a small number of cancer patients. In the past year, sales of Insys Therapeutics have soared and its share price has jumped nearly 270 percent. Over the last week, however, shares of Insys have lost roughly a third of their value after the arrest on federal fraud charges of a Michigan neurologist who was a top prescriber of Subsys.

Concern over Subsys are centered around aggressive marketing practices and off-label uses (uses the drug was not originally intended for), as the drug was approved to relieve cancer patients but fewer than 1% of prescribers are oncologists. Read more…

Share this:

  • Twitter
  • Email
  • More
  • Facebook
  • Reddit
  • Print

Tagged: Drug Abuse, Government Policy, Injury and Trauma, Regulatory Issues Leave a Comment

Previous Post
Next Post

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

Recent Posts

  • The Quality Divide: What Makes a Quality IME Physician?
  • The Quality Divide: Is Your Vendor Driving IME Excellence?
  • The Quality Divide: When and How to Request an IME?
  • April Clinic Calendars Are Available
  • MCN’s Client Portal Login Page is Changing

Archives

Footer


  • Twitter
  • LinkedIn

Quick Links

  • Services
  • Expertise
  • About MCN
  • Careers

Division Headquarters

MCN
1200 5th Ave., Ste. 650
Seattle, WA 98101

See all offices

Email Us

General Inquiries: info@mcn.com
Sales & Marketing: marketing@mcn.com

Call Us

206.343.6100
800.248.6269

© Copyright 2023 Mitchell International, Inc. All Rights Reserved.

  • Privacy Policy
  • Sitemap